Correlation Between Edgewise Therapeutics and Standard Biotools
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Standard Biotools at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Standard Biotools into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Standard Biotools, you can compare the effects of market volatilities on Edgewise Therapeutics and Standard Biotools and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Standard Biotools. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Standard Biotools.
Diversification Opportunities for Edgewise Therapeutics and Standard Biotools
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Standard is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Standard Biotools in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Standard Biotools and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Standard Biotools. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Standard Biotools has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Standard Biotools go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Standard Biotools
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Standard Biotools. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 2.21 times less risky than Standard Biotools. The stock trades about -0.11 of its potential returns per unit of risk. The Standard Biotools is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 175.00 in Standard Biotools on August 30, 2024 and sell it today you would earn a total of 7.00 from holding Standard Biotools or generate 4.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Standard Biotools
Performance |
| Timeline |
| Edgewise Therapeutics |
| Standard Biotools |
Edgewise Therapeutics and Standard Biotools Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Standard Biotools
The main advantage of trading using opposite Edgewise Therapeutics and Standard Biotools positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Standard Biotools can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Biotools will offset losses from the drop in Standard Biotools' long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Standard Biotools vs. Star Equity Holdings | Standard Biotools vs. Biodesix | Standard Biotools vs. ENDRA Life Sciences | Standard Biotools vs. Fonar |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |